Tenofovir News and Research

RSS
NIH launches large study to compare treatments for pregnant women with HIV

NIH launches large study to compare treatments for pregnant women with HIV

New HIV prevention guidelines from Canada released

New HIV prevention guidelines from Canada released

Study: PrEP program for men who have sex with men could lead to long-term cost savings

Study: PrEP program for men who have sex with men could lead to long-term cost savings

HIV pre-exposure prophylaxis (PrEP) could be cost saving for NHS in long run

HIV pre-exposure prophylaxis (PrEP) could be cost saving for NHS in long run

HIV prevention drug to be trialed by Britain's NHS

HIV prevention drug to be trialed by Britain's NHS

UTHealth participates in study to evaluate effectiveness of new injectable HIV medication

UTHealth participates in study to evaluate effectiveness of new injectable HIV medication

CDC guidelines for PrEP use to prevent HIV transmission do not go far enough, UCLA study suggests

CDC guidelines for PrEP use to prevent HIV transmission do not go far enough, UCLA study suggests

First large-scale clinical study of long-acting injectable HIV drug begins

First large-scale clinical study of long-acting injectable HIV drug begins

Added benefit of combination drug for HIV-infected patients not proven

Added benefit of combination drug for HIV-infected patients not proven

Study provides new insights into real-world use of PrEP

Study provides new insights into real-world use of PrEP

Studies shed new light on why young women in South Africa experience high rates of HIV infection

Studies shed new light on why young women in South Africa experience high rates of HIV infection

Researchers receive grant to test transcutaneously refillable implant that delivers HIV-prevention drugs

Researchers receive grant to test transcutaneously refillable implant that delivers HIV-prevention drugs

TDF reduces vertical HBV transmission

TDF reduces vertical HBV transmission

Maternal HBsAg can serve as HBV vertical transmission marker

Maternal HBsAg can serve as HBV vertical transmission marker

Topical delivery of AVR drug combination can provide complete protection against HIV

Topical delivery of AVR drug combination can provide complete protection against HIV

Nearly half of newly-infected HIV patients experience neurologic issues

Nearly half of newly-infected HIV patients experience neurologic issues

TDF, entecavir duo 'highly effective' for difficult-to-treat chronic HBV

TDF, entecavir duo 'highly effective' for difficult-to-treat chronic HBV

Renal risk factors for NA-treated HBV patients identified

Renal risk factors for NA-treated HBV patients identified

Real-world data confirm TDF efficacy for HBV

Real-world data confirm TDF efficacy for HBV

Resistance to prior antiviral agents impacts TDF response

Resistance to prior antiviral agents impacts TDF response